Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound sustained-release capsules for treating rheumarthritis and preparation method

A technology for rheumatoid arthritis and compound sustained-release tablets, which can be applied to medical preparations without active ingredients, medical preparations containing active ingredients, anti-inflammatory agents, etc. Large and other problems, to achieve the effect of improving body immunity, good effect and fast onset

Inactive Publication Date: 2015-11-25
QINGDAO HAIZHIYUAN INTELLIGENT TECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Western medicine treats rheumatoid arthritis with quick results and a short cycle, but has large side effects and is prone to complications; Chinese medicine treats rheumatoid arthritis with few side effects, but slow results and a long cure cycle

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound sustained-release capsules for treating rheumarthritis and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] A compound sustained-release tablet for treating rheumatoid arthritis. The components and parts by weight of the sustained-release tablet include: 3 parts of hydrocortisone, 22 parts of glucosamine sulfate, 13 parts of vitamin C, 52 parts of red dates, and 53 parts of black beans , 22 parts of Nuxychia, 33 parts of Speranth, 40 parts of Angelica, 42 parts of Ginger, 18 parts of Guizhi, 22 parts of Asarum, 42 parts of Aconitum, 33 parts of Shufu Tablets, 32 parts of Fangji, 42 parts of Sangzhi Coix seed 58 parts, Chixiaodou 57 parts, microcrystalline cellulose 27 parts, sodium carboxymethyl cellulose 12 parts, dry starch 8 parts, talcum powder 3 parts, Tween 4 parts, povidone 23 parts.

[0025] A preparation method for compound sustained-release tablets for the treatment of rheumatoid arthritis, comprising the following steps:

[0026] 1) preparing materials, preparing materials according to the components and parts by weight of a compound sustained-release tablet for th...

Embodiment 2

[0033] A compound sustained-release tablet for treating rheumatoid arthritis. The components and parts by weight of the sustained-release tablet include: 2 parts of hydrocortisone, 20 parts of glucosamine sulfate, 10 parts of vitamin C, 50 parts of red dates, and 50 parts of black beans , 20 parts of Nuxychia, 30 parts of Speranth, 35 parts of Angelica, 40 parts of Ginger, 15 parts of Guizhi, 20 parts of Asarum, 40 parts of Aconitum, 30 parts of Shufu Tablets, 30 parts of Fangji, 40 parts of Mori Coix seed 55 parts, Chixiaodou 55 parts, microcrystalline cellulose 25 parts, sodium carboxymethyl cellulose 10 parts, dry starch 5 parts, talcum powder 2 parts, Tween 3 parts, povidone 20 parts.

[0034] A preparation method for compound sustained-release tablets for the treatment of rheumatoid arthritis, comprising the following steps:

[0035] 1) preparing materials, preparing materials according to the components and parts by weight of a compound sustained-release tablet for the t...

Embodiment 3

[0042] A compound sustained-release tablet for treating rheumatoid arthritis. The components and parts by weight of the sustained-release tablet include: 5 parts of hydrocortisone, 25 parts of glucosamine sulfate, 15 parts of vitamin C, 55 parts of red dates, and 55 parts of black beans , 25 parts of Nuxychia, 40 parts of Speranth, 45 parts of Angelica, 45 parts of Ginger, 20 parts of Guizhi, 25 parts of Asarum, 45 parts of Aconitum, 35 parts of Shufu Tablets, 35 parts of Fangji, 45 parts of Sangzhi Coix seed 60 parts, Chixiaodou 60 parts, microcrystalline cellulose 30 parts, sodium carboxymethyl cellulose 15 parts, dry starch 10 parts, talcum powder 5 parts, Tween 6 parts, povidone 25 parts.

[0043] A preparation method for compound sustained-release tablets for the treatment of rheumatoid arthritis, comprising the following steps:

[0044] 1) preparing materials, preparing materials according to the components and parts by weight of a compound sustained-release tablet for t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses compound sustained-release capsules for treating rheumarthritis and a preparation method. The compound sustained-release capsules comprise the following components: hydrocortisone, ghcosamine sulfate, vitamin, red dates, black beans, semen strychni, garden balsam stem, angelica sinensis, fresh ginger, cassia twig, asarum, radix aconite, radix aconitilateralis preparata, radix stephaniae tetrandrae, mulberry twig, coix seeds, rice bean seeds, microcrystalline cellulose, sodium carboxymethyl cellulose, dry starch, talcum powder, tween and polyvidone. Synergistic effects of the various components of the compound sustained-release capsules are good, and the rheumarthritis can be treated quickly and effectively and cannot relapse easily. Moreover, the compound sustained-release capsules treat both symptoms and root causes, and can treat arthritis in a radical manner while quickly relieving swelling and pain; body functions can be regulated, antibody formation is promoted, immune defenses are improved, recovery of the rheumarthritis is facilitated, and the rheumarthritis is prevented from relapsing.

Description

technical field [0001] The invention belongs to the technical field of treating rheumatoid arthritis, and specifically relates to a compound sustained-release tablet for treating rheumatoid arthritis and a preparation method thereof. Background technique [0002] Rheumatoid arthritis is an allergic disease and is one of the main manifestations of rheumatic fever. It usually starts with acute fever and joint pain. The typical manifestations are mild or moderate fever and migratory polyarthritis. The affected joints are mostly Large joints such as knees, ankles, shoulders, elbows, and wrists are often transferred from one joint to another. The lesion is locally red, swollen, burning, and painful. Some patients also have several joints at the same time. Atypical patients only have Joint pain without other inflammatory manifestations. Acute inflammation usually subsides in 2 to 4 weeks without sequelae, but often recurs. If rheumatic activity affects the heart, myocarditis can ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61K9/22A61K47/38A61P19/02A61P29/00A61K31/573A61K31/375A61K31/79A61K31/7008
Inventor 袁国防周丽萍王小雅孙可欣王巧卓
Owner QINGDAO HAIZHIYUAN INTELLIGENT TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products